News Bulletin
Friday, October 23, 2026
Evening Edition
Economic Numbers:
|
Time |
Event |
Actual |
Forecast |
Previous |
|
9:45 |
5790.00% |
57.9 |
5880.00% |
|
|
9:45 |
5600.00% |
55.4 |
5590.00% |
|
|
9:45 |
5760.00% |
57.6 |
5840.00% |
|
|
10:00 |
4.70% |
0.047 |
4.60% |
|
|
10:00 |
4880.00% |
47.3 |
4630.00% |
|
|
10:00 |
4800.00% |
46.3 |
4810.00% |
|
|
10:00 |
3.50% |
0.035 |
3.40% |
|
|
10:00 |
4670.00% |
44.7 |
5090.00% |
|
|
13:00 |
46000.00% |
|
45900.00% |
|
|
13:00 |
60300.00% |
|
60300.00% |
Indices
|
|
CLOSE |
50 DMA |
200 DMA |
|
DJIA |
52,215.16 |
52,320.95 |
50,532.54 |
|
NASDAQ |
25,955.34 |
26,599.16 |
24,992.03 |
|
S&P 500 |
7,623.68 |
7,699.71 |
7,289.64 |
Earnings Calendar:
(EPS: Earning Per Share / Rev: Revenue / Mkt Cap : market Capital/ BMO :
Before Market Opening /AMC : After Market Close)
|
COMPANY |
EPS Act |
EPS
Fore |
Rev
Act |
Rev
Fore |
Mkt Cap |
Fiscal |
Time |
|
$228.31B |
Q3 |
AM |
|||||
|
$75.35B |
Q3 |
AM |
|||||
|
$28.73B |
Q3 |
AM |
|||||
|
-/- |
-/- |
$15.64B |
Q3 |
PM |
|||
|
$9.51B |
Q2 |
AM |
|||||
|
$6.25B |
Q3 |
AM |
|||||
|
$5.36B |
Q3 |
AM |
|||||
|
$5.19B |
Q3 |
AM |
|||||
|
$4.69B |
Q3 |
AM |
|||||
|
$4.31B |
Q3 |
AM |
|||||
|
-/0.82 |
-/250.7M |
$2.74B |
Q3 |
PM |
|||
|
-/0.33 |
-/998.1M |
$1.68B |
Q3 |
PM |
|||
|
-/0.86 |
-/798.93M |
$1.48B |
Q3 |
AM |
|||
|
-/6.49 |
-/187.05M |
$1.18B |
Q3 |
AM |
Market
News:
Here are some of the biggest premarket US stock movers today:
Instacart (CART) closed up 9.2% on Friday after The
Information reported the grocery-delivery company was exploring a sale and had
held preliminary discussions with Uber (UBER) and DoorDash (DASH). Shares of both potential buyers hit
session lows.
Middlesex
Water (MSEX) declared a quarterly dividend of $0.38 per share,
or $1.52 annualized. This is a 5.6% increase from the prior dividend of $0.36. The
dividend will be payable on December 1, 2026, to stockholders of record on
November 16, 2026, with an ex-dividend date of November 13, 2026.
Climb Bio
Inc. (NASDAQ:CLYM) and Beijing Mabworks
Biotech Co. Ltd. announced Phase 1 data for CLYM116/MIL116, an anti-APRIL
monoclonal antibody in development for IgA
nephropathy, according to a press release statement.
Stem, Inc.
(NYSE:STEM) disclosed that it received a non-compliance letter
from the New York Stock Exchange regarding its failure to meet minimum listing
requirements.
Ardelyx Inc. (NASDAQ:ARDX) presented real-world analysis results
today at the American Society of Nephrology Kidney Week 2026 evaluating serum
phosphate outcomes in adults on dialysis who initiated XPHOZAH.
ArriVent BioPharma, Inc. (NASDAQ:AVBP)
announced that initial safety and efficacy data from its Phase 1 study of
ARR-217 will be presented at the European Society for Medical Oncology Congress
2026 in Madrid, Spain, according to a press release statement.
Salesforce (NYSE:CRM) granted 278,068 restricted stock units
to 34 employees from recently acquired companies m3ter and Fin, according to a
press release statement.
For internal use only